A publication in Nature in April 2026 reports that N-desethyl-fluornitrazene (DFNZ), a modified nitazene and µ-opioid receptor (MOR) superagonist, produced potent analgesia in rodents with less respi… [+4610 chars]
Read Full Story
- Home
- Kenya News
- How the opioid superagonist DFNZ challenges pain medicine
Related Post
BSF DG leads Jammu Marathon, first such initiative since Op Sindoor
STATE TIMES NEWS JAMMU: BSF Director General Daljit Singh Chawdhary on Sunday flagged off the Jammu Marathon, marking the first…
The 50 Most Powerful PR Firms of 2026
Power is more than size, scope, revenue or retention. Power is the ability to move capital, culture and conversation across…
Ofweneke Shares Heartwarming Post Tagging Ex Nicah as Daughter Joins Top High School
Dr Ofweneke and Nicah celebrate daughter Faith’s high school transition despite their separation Faith excelled in KJSEA, earning her place…
How to watch Atletico Madrid vs Arsenal: Free Streams for Champions League 2025/26 Semi-Final 1st leg
Today’s Atletico Madrid vs Arsenal live stream sees two of the four remaining teams in the 2025/26 Champions League commence…
Kenya seeks to strike US trade deal by end of year, Trade CS Kinyanjui says
Kenya expects to conclude a trade deal with the United States by year-end, its trade minister told Reuters, a move…